FDAnews
www.fdanews.com/articles/203621-dexcom-gains-fda-510k-clearance-for-glucose-data-software

Dexcom Gains FDA 510(k) Clearance for Glucose Data Software

July 20, 2021

Dexcom’s Partner Web APIs (application programming interfaces) have earned 510(k) clearance from the FDA, enabling third-party developers to integrate continuous glucose monitoring data into their digital health software apps and devices.

San Diego, Calif.-based Dexcom has invited several diabetes and digital health companies to use the software interface tools for their products, including Garmin and Teladoc Health’s Livongo for Diabetes, which is now in the testing and development phase.

The web APIs allow users to quickly see all their therapy data in one place and also provide diabetes management coaching and feedback.

View today's stories